Summary of MEDIVATION, INC.

Change in Directors or Principal Officers, Financial Statements and Exhibits

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

2012 Bonuses

On December 7, 2012, the Compensation Committee of the Board of Directors (the "Committee") of Medivation, Inc. (the "Company") approved cash bonuses for the Company's executive officers pursuant to the Company's 2012 Bonus Plan, as previously described in the Company's Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on June 1, 2012, in recognition of both the level of the Company's achievement of its corporate goals for 2012 and each named executive officer's contributions toward the achievement of those goals. The bonuses awarded to the named executive officers are set forth in Exhibit 10.1 hereto and are incorporated herein by reference.

2013 Salaries

On December 7, 2012, the Committee approved new base salaries, effective January 1, 2013, for the Company's executive officers in the amounts set forth in Exhibit 10.1 hereto, which is incorporated herein by reference.

2013 Bonus Plan

On December 7, 2012, the Committee approved a 2013 bonus plan for the Company's executive officers, which bonus plan is summarized in Exhibit 10.2 hereto and incorporated herein by reference.

Equity Awards

On December 7, 2012, the Committee approved the grant of stock options and
restricted stock units ("RSUs") under the Company's Amended and Restated 2004
Equity Incentive Award Plan (the "2004 Plan") to the Company's Chief Executive
Officer and other named executive officers. The number of shares of the
Company's common stock underlying the grants is set forth in the table below:



                                             Number of Shares of             Number of Shares of
                                           Common Stock Underlying         Common Stock Underlying
Named Executive Officer                         Stock Options              Restricted Stock Units
David Hung, M.D.                                   155,000                         31,000
  President and Chief Executive
Officer
Cheryl Cohen                                       45,000                           9,000
  Chief Commercial Officer
C. Patrick Machado                                 45,000                           9,000
  Chief Business Officer and Chief
Financial Officer
Lynn Seely, M.D.                                   45,000                           9,000
  Chief Medical Officer

The grant date of the stock options, determined in accordance with the Company's Stock Option Grant Date Policy, will be December 17, 2012. One-fourth of the shares subject to the stock options will vest and become exercisable on the first anniversary of the grant date, and the remaining three-fourths of the shares will vest monthly over the three years thereafter, subject to continued service. The stock options will have an exercise price equal to the fair market value per share of the Company's common stock on the grant date, as determined in accordance with the terms of the 2004 Plan, and a term of 10 years from the grant date.

-1-

The grant date of the RSUs was December 7, 2012. The RSUs will vest annually over three years beginning on December 3, 2012, subject to continued service.

The description of the stock options contained herein is a summary of their material terms, does not purport to be complete and is qualified in its entirety by reference to the Stock Option Grant Notice and Stock Option Agreement for use in connection with the grant of the Options, which were filed with the Company's Annual Report on Form 10-KSB filed with the Securities and Exchange Commission on February 11, 2005 and incorporated herein by reference to this Current Report on Form 8-K.

The description of the RSUs contained herein is a summary of their material terms, does not purport to be complete and is qualified in its entirety by reference to the Restricted Stock Unit Grant Notice and Agreement for use in connection with the grant of the restricted stock units, which was filed with the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 29, 2012 and incorporated herein by reference to this Current Report on Form 8-K.